Dr. Daniel Remick selected as the Editor-in-Chief of the journal SHOCK®

Daniel G. Remick, MD
Professor of Pathology & Laboratory Medicine
Boston University School of Medicine

Daniel Remick, MD has been appointed as the Editor-in-Chief for the scientific journal Shock® Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches.

SHOCK® publishes papers detailing novel therapeutic approaches including immunomodulation, gene therapy, nutrition, and others. The journal’s mission fosters and promotes multidisciplinary studies that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiology. The journal excels as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related states. Papers in Shock® emphasize biologic mechanisms that determine the response to injury since this information ultimately facilitates improved care of the traumatized or septic individual.

Shock® is The Official Journal of the Shock Society, the European Shock Society, the Indonesian Shock Society, the International Federation of Shock Societies, and the Official and International Journal of the Japan Shock Society.

Dr. Remick is a Past President of the ASIP and continues to be active on several of our committees, including the Research and Science Policy Committee (RSPC) and Publications Committee.

“I am honored to have been selected as the Editor-in-Chief for the journal Shock. My time on the editorial board of the American Journal of Pathology has helped me with ideas on how to improve the quality of the journal, and I am grateful to Drs. Furie and Roth for their mentorship while they served as Editors-in-Chief.”

Daniel Remick, MD